When to suspect and how to diagnose pulmonary lymphangioleiomyomatosis.
The objective of this study was to present clinical and radiological data of eight women with histologically proven lymphangioleiomyomatosis (LAM) diagnosed between 1984 and 1994, and to suggest a diagnostic strategy when LAM is suspected. A review of case reports, including results of biopsies, lung function and radiological procedures was undertaken. The mean age of the women at start of symptoms was 36 years, and the mean age at time of diagnosis 42 years. The most frequent presenting complaint was dyspnea, either in conjunction with pneumothorax (3), chylothorax (2) or on exertion (2). All patients had airflow limitation and markedly reduced gas transfer. Five patients had 16 episodes of pneumothorax. In seven patients multiple cysts were observed on the surface of the lung during thoracotomy while computerized tomography (CT) scans revealed numerous cysts evenly distributed throughout the lung parenchyma. The procedures that confirmed the diagnosis included transbronchial lung biopsy (4), open lung biopsy (2), thoracoscopy (1), thoracotomy (3) and autopsy (1). Three specimens had to be revised before the histological diagnosis was confirmed. It was concluded that the important clues to a diagnosis of LAM are recurrent episodes of pneumothoraces in fertile women, progressive air-flow limitation, markedly reduced gas transfer and characteristic findings on thoracic CT scans. A specific request to the pathologist to stain lung tissue specimens for smooth muscle cells is mandatory.
Naalsund
A
A
Department of Thoracic Medicine, National Hospital, University of Oslo, Norway.
Johansen
B
B
Foerster
A
A
Kolbenstvedt
A
A
D000328:Adult; D001707:Biopsy, Needle; D003937:Diagnosis, Differential; D005260:Female; D006801:Humans; D008168:Lung / Q000473:pathology; D008175:Lung Neoplasms / Q000175:diagnosis* / Q000401:mortality / Q000473:pathology / Q000628:therapy; D016040:Lung Transplantation; D018192:Lymphangioleiomyomatosis / Q000175:diagnosis* / Q000401:mortality / Q000473:pathology / Q000628:therapy; D008525:Medroxyprogesterone / Q000627:therapeutic use; D008875:Middle Aged; D018700:Pleurodesis; D045167:Progesterone Congeners / Q000627:therapeutic use; D011379:Prognosis; D012129:Respiratory Function Tests; D014057:Tomography, X-Ray Computed
D045167:Progesterone Congeners; D008525:Medroxyprogesterone